Recombinant Human TNF Receptor II Protein (Active) is a Human Fragment protein, in the 24 to 206 aa range, expressed in HEK 293, with >=95% purity, <= 0.005 EU/µg endotoxin level and suitable for HPLC, MS, SDS-PAGE.
P A Q V A F T P Y A P E P G S T C R L R E Y Y D Q T A Q M C C S K C S P G Q H A K V F C T K T S D T V C D S C E D S T Y T Q L W N W V P E C L S C G S R C S S D Q V E T Q A C T R E Q N R I C T C R P G W Y C A L S K Q E G C R L C A P L R K C R P G F G V A R P G T E T S D V V C K P C A P G T F S N T T S S T D I C R P H Q I C N V V A I P G N A S M D A V C T S T S P T
Application | Reactivity | Dilution info | Notes |
---|---|---|---|
Application HPLC | Reactivity Reacts | Dilution info - | Notes - |
Application MS | Reactivity Reacts | Dilution info - | Notes - |
Application SDS-PAGE | Reactivity Reacts | Dilution info - | Notes - |
Receptor with high affinity for TNFSF2/TNF-alpha and approximately 5-fold lower affinity for homotrimeric TNFSF1/lymphotoxin-alpha. The TRAF1/TRAF2 complex recruits the apoptotic suppressors BIRC2 and BIRC3 to TNFRSF1B/TNFR2. This receptor mediates most of the metabolic effects of TNF-alpha. Isoform 2 blocks TNF-alpha-induced apoptosis, which suggests that it regulates TNF-alpha function by antagonizing its biological activity.
CD120b, TNFBR, TNFR2, TNFRSF1B, Tumor necrosis factor receptor superfamily member 1B, Tumor necrosis factor receptor 2, Tumor necrosis factor receptor type II, p75, p80 TNF-alpha receptor, TNF-R2, TNF-RII, TNFR-II
Recombinant Human TNF Receptor II Protein (Active) is a Human Fragment protein, in the 24 to 206 aa range, expressed in HEK 293, with >=95% purity, <= 0.005 EU/µg endotoxin level and suitable for HPLC, MS, SDS-PAGE.
ED50 is ≤ 1.9 ug/ml, corresponding to a specific activity of 5.26 x 102 units/mg.
pH: 7.4
Constituents: 10.26% Trehalose, 0.727% Dibasic monohydrogen potassium phosphate, 0.248% Potassium phosphate monobasic
SDS-PAGE >= 95%
Receptor with high affinity for TNFSF2/TNF-alpha and approximately 5-fold lower affinity for homotrimeric TNFSF1/lymphotoxin-alpha. The TRAF1/TRAF2 complex recruits the apoptotic suppressors BIRC2 and BIRC3 to TNFRSF1B/TNFR2. This receptor mediates most of the metabolic effects of TNF-alpha. Isoform 2 blocks TNF-alpha-induced apoptosis, which suggests that it regulates TNF-alpha function by antagonizing its biological activity.
Phosphorylated; mainly on serine residues and with a very low level on threonine residues.
This product is an active protein and may elicit a biological response in vivo, handle with caution.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
Mass determination by ESI-TOF. Predicted MW is 19899.44 Da (+/-10 Da by ESI-TOF). Observed MW is 19899.96 Da.
Fully biologically active determined by the dose dependent inhibition of TNF alpha induced NF-ƙb activation in mouse RAW 264.7 NF-ƙb luciferase reporter cell line.
ED50 is ≤ 1.9 ug/ml, corresponding to a specific activity of 5.26 x 102 units/mg.
SDS-PAGE analysis of ab290100
HPLC analysis of ab290100
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com